Four Former FDA Commissioners: Drug Importation to Reduce Costs is 'Complex and Risky'
By Zachary Brennan -
Published 20 March 2017
As Congress looks to address the problem of rising prescription drug prices, four former US Food and Drug Administration (FDA) commissioners told members in an open letter from last week that importing cheaper medicines from Canada and elsewhere is "a complex and risky approach."
Categories: News, US, FDA, Crisis management, Drugs, Government affairs, Regulatory intelligence, Regulatory strategy
Tags: drug imports, Bernie Sanders, Califf, Hamburg, commissioners on drug imports